Activity

Filter

Cancel
Date Panel Item Activity
5 actions
Leukodystrophy - paediatric v0.243 ABCC9 Zornitza Stark Marked gene: ABCC9 as ready
Leukodystrophy - paediatric v0.243 ABCC9 Zornitza Stark Gene: abcc9 has been classified as Amber List (Moderate Evidence).
Leukodystrophy - paediatric v0.243 ABCC9 Zornitza Stark Classified gene: ABCC9 as Amber List (moderate evidence)
Leukodystrophy - paediatric v0.243 ABCC9 Zornitza Stark Gene: abcc9 has been classified as Amber List (Moderate Evidence).
Leukodystrophy - paediatric v0.242 ABCC9 Zornitza Stark gene: ABCC9 was added
gene: ABCC9 was added to Leukodystrophy - paediatric. Sources: Literature
Mode of inheritance for gene: ABCC9 was set to BIALLELIC, autosomal or pseudoautosomal
Publications for gene: ABCC9 were set to 31575858
Phenotypes for gene: ABCC9 were set to Intellectual disability and myopathy syndrome, MIM# 619719
Review for gene: ABCC9 was set to AMBER
Added comment: PMID 31575858: Report of 6 cases from 2 families, all with homozygous c.1320+1G>A. Phenotype of mild ID, similar facies, myopathy, cerebral white matter hyperintensities, and cardiac systolic dysfunction in the oldest cases.
'This mutation results in an in-frame deletion of exon 8, which results in non-functional KATP channels in recombinant assays. SUR2 loss-of-function causes fatigability and cardiac dysfunction in mice, and reduced activity, cardiac dysfunction and ventricular enlargement in zebrafish. We term this channelopathy resulting from loss-of-function of SUR2-containing KATP channels ABCC9-related Intellectual disability Myopathy Syndrome (AIMS). The phenotype differs from CantĂș syndrome, which is caused by gain-of-function ABCC9 mutations, reflecting the opposing consequences of KATP loss- versus gain-of-function'.
Sources: Literature